Concepedia
2
Publications
72
Citations
H-Index
2022
Active since
Affiliations
Altoona Center for Clinical Research(Current)
Selecta Biosciences (United States)
Earl Sands is an author at Altoona Center for Clinical Research.
Publications per year
2022–2023
Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
Earl Sands, Alan Kivitz, Wesley DeHaan et al. · Nature Communications · 2022 · 51 citations · Full text
Phase 2 Dose-Finding Study in Patients with Gout Using SEL-212, a Novel PEGylated Uricase (SEL-037) Combined with Tolerogenic Nanoparticles (SEL-110)
Alan Kivitz, Wesley DeHaan, Rehan Azeem et al. · Rheumatology and Therapy · 2023 · 21 citations · Full text
Rows per page
1–2 of 2